Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Operating Leases (2021 - 2025)

BioAtla's Operating Leases history spans 5 years, with the latest figure at $4.8 million for Q4 2025.

  • For Q4 2025, Operating Leases changed N/A year-over-year to $4.8 million; the TTM value through Dec 2025 reached $4.8 million, changed N/A, while the annual FY2025 figure was $4.8 million, N/A changed from the prior year.
  • Operating Leases reached $4.8 million in Q4 2025 per BCAB's latest filing, down from $5.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $5.2 million in Q2 2025 to a low of $415000.0 in Q1 2024.
  • Average Operating Leases over 5 years is $2.7 million, with a median of $2.5 million recorded in 2022.
  • Peak YoY movement for Operating Leases: soared 118.09% in 2022, then tumbled 79.88% in 2024.
  • A 5-year view of Operating Leases shows it stood at $1.1 million in 2021, then skyrocketed by 118.09% to $2.5 million in 2022, then tumbled by 66.02% to $836000.0 in 2023, then crashed by 50.36% to $415000.0 in 2024, then skyrocketed by 1050.12% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Operating Leases are $4.8 million (Q4 2025), $5.0 million (Q3 2025), and $5.2 million (Q2 2025).